SVA Share Price

Open 0.28 Change Price %
High 0.28 1 Day -0.02 -7.14
Low 0.26 1 Week -0.01 -3.70
Close 0.26 1 Month 0.00 0.00
Volume 201000 1 Year 0.00 0.00
52 Week High 0.40
52 Week Low 0.22
SVA Important Levels
Resistance 2 0.28
Resistance 1 0.27
Pivot 0.27
Support 1 0.25
Support 2 0.24
CVE Canada Most Active Stocks
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
PRY 0.02 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
COD 0.07 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
DVN 0.17 0.00%
More..
CVE Canada Top Gainers Stocks
TUF 0.02 100.00%
AZU 0.02 100.00%
AZU 0.02 100.00%
ADE 0.02 100.00%
BVQ 0.02 100.00%
DDX 0.50 100.00%
RDM 0.21 90.91%
RDM 0.21 90.91%
PMC 0.06 50.00%
PMC 0.06 50.00%
More..
CVE Canada Top Losers Stocks
TCI 0.08 -55.56%
TCI 0.08 -55.56%
TCI 0.08 -55.56%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
FEM 0.02 -50.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
BMA 0.06 -40.00%
More..

Sernova Corp (CVE: SVA)

SVA Technical Analysis 2
As on 24th Apr 2017 SVA Share Price closed @ 0.26 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.28 & Buy for SHORT-TERM with Stoploss of 0.26 we also expect STOCK to react on Following IMPORTANT LEVELS.
SVA Target for April
1st Target up-side 0.3
2nd Target up-side 0.32
3rd Target up-side 0.35
1st Target down-side 0.22
2nd Target down-side 0.2
3rd Target down-side 0.17
SVA Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.sernova.com
SVA Address
SVA
700 Collip Circle
Suite 114
London, ON N6G 4X8
Canada
Phone: 519-858-5184
Fax: 519-858-5099
SVA Latest News
The Sernova Corp. (SVA) Director Sells C$41625.00 in Stock   Petro Global News 24   - 25th Apr 17
Scott Langille Buys 50000 Shares of Sernova Corp. (SVA) Stock   The Cerbat Gem   - 24th Apr 17
Sernova Corp. (SVA) Insider Scott Langille Buys 50000 Shares   BBNS   - 22nd Apr 17
Scott Langille Buys 100000 Shares of Sernova Corp. (SVA) Stock   The Cerbat Gem   - 21st Apr 17
Sernova Corp. (SVA) Director Sells C$41625.00 in Stock   Sports Perspectives   - 20th Apr 17
Sernova Corp. (SVA) Director James Todd Parsons Sells 166500 Shares   The Cerbat Gem   - 17th Apr 17
Sernova Announces Appointment of New CFO   Marketwired (press release)   - 30th Sep 16
JDRF backs Sernova's implant for T1D   Mass Device   - 08th Sep 16
Sernova Receives Issued Patent in the United States for Its Cell Pouch™ and ...   Marketwired (press release)   - 23rd Apr 15
Medical breakthrough   London Free Press   - 10th May 12
Interactive Technical Analysis Chart Sernova Corp ( SVA CVE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sernova Corp
SVA Business Profile
Sernova Corp., a clinical-stage health sciences company, focuses on the development and commercialization of medical technologies. The company’s proprietary platform technologies include Cell Pouch System, a scalable device providing a natural organ-like environment for therapeutic cells, such as insulin producing islets for diabetics; and Sertolin, a cell-based technology providing an immune-privileged environment for donor cells, reducing or eliminating the need for anti-rejection drugs. It also intends to commercialize the products for parkinson’s, spinal cord injury, and haemophilia diseases. The company is headquartered in London, Canada.